AARD · Aardvark Therapeutics, Inc.
$6.62
-0.19 (-2.79%)
At close · Aug 27
Market Cap
$149.04M
Shares
21.88M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$57.59M
-179.7%
FY2025
Diluted EPS
-$2.93
+43.1%
FY2025
Operating Cash Flow
-$54.17M
-199.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| — | $0 | — | |
| $4.06M | $5.14M | $2.41M | |
| $55.06M | $48.94M | $17.36M | |
| $18.9M | $13.79M | $5.31M | |
| — | $36K | $16K | |
| $73.96M | $62.73M | $22.79M | |
| -$73.96M | -$62.73M | -$22.79M | |
| — | -$62.69M | -$22.77M | |
| $4.07M | $5.13M | $2.2M | |
| — | $0 | $0 | |
| -$69.89M | -$57.59M | -$20.59M | |
| -$69.89M | -$57.51M | -$20.59M | |
| USD/shares | -$3.21 | -$2.93 | -$5.15 |
| USD/shares | -$3.21 | -$2.93 | -$5.15 |
| shares | — | 19.62M | 4M |
| shares | — | 19.62M | 4M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.73×
EV/EBIT
—
Peer median 12.45×
P/E (TTM)
—
Peer median 10.33×
Peer medians compare against the 303 similar-size Biotechnology companies (of 534 listed).
Key facts
CIK
1774857
CUSIP
002942100
13F (30d)
59 filings
59 filers
Visit website
Investor relations